TrialCancer immunology, immunotherapy : CII2008

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

Asna Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.